Skip to main content

Table 1 Mean change in global outcomes from baseline to 60 days

From: Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial

 

Placebo/Bacillus coagulans GBI-30, 6086

Difference in Means (95% CI)

P Valuea

Score

22/22

0.006 (-0.33, 0.35)

.97

Pain

21/22

0.46 (0.01, 0.91)

.046

Patient global

22/22

0.047 (-0.38, 0.47)

.83

Patient pain

22/22

0.41 (-0.004, 0.82)

.052

Patient disability

22/22

0.19 (-0.16, 0.54)

.28

Physician global

22/22

0.019 (-0.62, 0.66)

.95

Painful joints

22/22

-0.074 (-0.81, 0.66)

.84

Swollen joints

22/22

0.011 (-0.62, 0.64)

.97

ESR

21/21

-0.054 (-0.49, 0.38)

.80

CRP

22/22

0.008 (-0.52, 0.53)

.98

  1. Score = the mean of the eight category scores in the HAQ.
  2. ESR = erythrocyte sedimentation rate.
  3. CRP = C-reactive protein.
  4. a P values calculated using Student's t test for group differences in the mean change scores from baseline to 60 days (95% confidence interval).